Company / Shares Outstanding
Lineage Cell Therapeutics, Inc. Shares Outstanding History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Shares Outstanding
220.4M
FY2025
5-year range
153.1M / 220.4M
FY2021-FY2025
Trend
+26.0%
vs FY2024
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Shares Outstanding has increased for 9 consecutive years, from 90421554.00 in FY2016 to 220416326.00 in FY2025.
Based on SEC 10-K filings.
220416326.00 in FY2025 with a 5-year CAGR of +8.0%.
Increased from 170093114.00 to 220416326.00 over the past 2 years.
Shares Outstanding over time
Growth rates
- 3-Year CAGR
- +9.2%
- 5-Year CAGR
- +8.0%
- 10-Year CAGR
- -
Key checks
Key Insights
- Lineage Cell Therapeutics, Inc.'s shares outstanding has grown for 9 consecutive years.
- In FY2025, shares outstanding increased 26.0% year-over-year.
- Lowest shares outstanding in the period was in FY2016.
Company context
Key Data Points
- Altman Z-Score -3.82 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Shares OutstandingValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | 220.4M | +26.0% |
| FY2024 | 175.0M | +2.9% |
| FY2023 | 170.1M | +0.4% |
| FY2022 | 169.5M | +10.7% |
| FY2021 | 153.1M | +2.2% |
| FY2020 | 149.8M | +17.8% |
| FY2019 | 127.1M | +0.2% |
| FY2018 | 126.9M | +23.4% |
| FY2017 | 102.8M | +13.7% |
| FY2016 | 90.4M | +15.6% |
As of FY2025 · SEC 10-K · Updated Jun 24, 2026